| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Gm Gene Therapy
1 company
Buck Jill serves as an EVP, Gm Gene Therapy at TCRT. Across recent SEC filings that breaks down to 0 buys and 2 sells. Those positions are worth an estimated $460K at current prices.
The biggest single holding is TCRT (~$460K) as EVP, Gm Gene Therapy. The recent filings there lean toward selling, a net 55,817 shares.